Trained Macrophage Bioreactor for Penetrating Delivery of Fused Antitumor Protein-Reference-Cited by-同舟云学术

Trained Macrophage Bioreactor for Penetrating Delivery of Fused Antitumor Protein

Published:2019-06-19 Issue:26 Volume:11 Page:23018-23025
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Zhang Yu¹,Zhang Yujie¹,Guo Qin¹,Guo Zhongyuan¹,Chen Xinli¹,Liu Lisha¹,Li Chao¹,Chen Qinjun¹,He Xi¹,Lu Yifei¹,Sun Tao¹,Huang Yongzhuo²^ORCID,Jiang Chen¹^ORCID

Affiliation:

1. Key Laboratory of Smart Drug Delivery, Ministry of Education, State Key Laboratory of Medical Neurobiology, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China

2. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

Funder

National Science Fund for Distinguished Young Scholars

Fudan-SIMM Joint Research Fund

Program of Shanghai Academic Research Leader

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.9b06097

Reference41 articles.

1. Effective Integration of Targeted Tumor Imaging and Therapy Using Functionalized InP QDs with VEGFR2 Monoclonal Antibody and miR-92a Inhibitor

2. Complement in monoclonal antibody therapy of cancer

3. Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy

4. Antibody constructs in cancer therapy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophages as Targets in Hepatocellular Carcinoma Therapy;Molecular Cancer Therapeutics;2024-02-02

2. Pharmacy Education, Practice, and Research in China;Handbook of Medical and Health Sciences in Developing Countries;2024

3. Tumor microenvironment as a bioreactor for Au&Fe3O4-DNA complex synthesis and targeted cancer therapy;Chemical Engineering Journal;2023-07

4. Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy;Cell Death Discovery;2023-02-15

5. Leveraging macrophages for cancer theranostics;Advanced Drug Delivery Reviews;2022-04